About Ceban
Ceban is a company based in Breda (Netherlands) founded in 2004 was acquired by Medios AG in March 2024. Ceban has completed 1 acquisition, including Bipharma. Ceban offers products and services including Compounding Services and HomeCare Services. Ceban operates in a competitive market with competitors including Fagron, Ignota Labs, RareStone Group, Revelation Pharma and Pharmedium, among others.
- Headquarter Breda, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ceban Pharmaceuticals B.V.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ceban
Ceban offers a comprehensive portfolio of products and services, including Compounding Services and HomeCare Services.
Prepares personalized medications for hospitals and pharmacies.
Administers medications at home by registered nurses.
Funding Insights of Ceban
Detailed funding history for Ceban
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Ceban
Ceban has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bencis and Medios AG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward growth in selected sectors.
|
Locked | Locked | Locked | |
|
Delivers specialty pharmaceuticals and advanced therapies for healthcare stakeholders.
|
Locked | Locked | Locked |
Investor details for Ceban
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ceban
Ceban has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bipharma.
Investment portfolio details for Ceban
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical products are distributed by Bipharma in the Netherlands.
|
Locked | Locked | 1946 | Locked |
Complete acquisition details for Ceban
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ceban
Detailed financials for Ceban
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ceban Comparisons
Peer comparison for Ceban
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ceban
Ceban operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fagron, Ignota Labs, RareStone Group, Revelation Pharma and Pharmedium, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug compounding services are provided by Fagron.
|
|
| Locked | Locked | Locked |
AI-driven toxicity prediction tools for early-stage drug discovery scientists
|
|
| Locked | Locked | Locked |
Provider of network and treatments to individuals and their families affected by rare diseases drugs
|
|
| Locked | Locked | Locked |
A network of compounding pharmacies is operated nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided to healthcare facilities nationwide.
|
|
| Locked | Locked | Locked |
Drug compounding services are provided by Syntis in healthcare.
|
Detailed competitors of Ceban
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ceban
Complete news archive for Ceban
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceban
Ceban was founded in 2004.
Ceban is headquartered in Breda, Netherlands. It is registered at Breda, Noord-brabant, Netherlands.
Ceban was established in 2004 as a standalone compounding pharmacy based in Breda, Netherlands. Operations focus on the preparation of customized medications tailored to individual patient needs within the pharmaceutical sector. Services encompass the formulation and dispensing of compounded drugs, adhering to regulatory standards for quality and safety. The company serves local healthcare providers and patients, maintaining a specialized role outside larger retail pharmacy networks.
Ceban's top competitors include Syntis, Ignota Labs and Fagron.
Ceban offers Compounding Services and HomeCare Services.
Ceban has made 1 acquisition, including Bipharma.